Medpace Holdings, Inc. Common Stock (MEDP)

Price$454.25

Value ScoreD

Growth ScoreA

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-31.25%

Price vs S&P 500 (4W)7.14%

VGM Score56.53

Market Capitalization$12.97B

P/E Ratio (Annual)28.76x

All Metrics

P/CF (Annual)18.19x

Book Value / Share (Quarterly)$21.00

P/TBV (Annual)37.17x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)20.12%

Cash Flow / Share (Quarterly)$24.96

Price vs S&P 500 (YTD)-27.28%

Gross Margin (TTM)29.07%

Net Profit Margin (TTM)17.19%

EPS (TTM)$15.89

10-Day Avg Trading Volume0.27M

EPS Excl Extra (TTM)$15.89

Revenue Growth (5Y)22.27%

EPS (Annual)$15.28

ROI (Annual)98.27%

Gross Margin (Annual)30.06%

Net Profit Margin (5Y Avg)16.94%

Cash / Share (Quarterly)$22.91

P/E Basic Excl Extra (TTM)28.18x

Revenue Growth QoQ (YoY)26.50%

EPS Growth (5Y)31.70%

P/E Normalized (Annual)28.76x

ROA (Last FY)22.84%

Revenue Growth TTM (YoY)24.19%

EBITD / Share (TTM)$20.40

ROE (5Y Avg)56.09%

Operating Margin (TTM)21.02%

Cash Flow / Share (Annual)$24.09

P/B Ratio21.68x

P/B Ratio (Quarterly)22.92x

Net Income / Employee (Annual)$71,600

EV / Revenue (TTM)4.60x

Net Interest Coverage (TTM)139.88x

ROA (TTM)24.79%

EPS Growth QoQ (YoY)16.43%

EV / EBITDA (TTM)20.85x

EPS Incl Extra (Annual)$15.28

Current Ratio (Annual)0.74x

Quick Ratio (Quarterly)0.78x

3-Month Avg Trading Volume0.39M

52-Week Price Return54.73%

EV / Free Cash Flow (Annual)18.07x

P/E Incl Extra (TTM)28.18x

Revenue / Employee (TTM)$425,100

Tangible BV / Share (Quarterly)$19.83

P/S Ratio (Annual)5.13x

Asset Turnover (Annual)1.28x

52-Week High$628.92

Operating Margin (5Y Avg)19.33%

EPS Excl Extra (Annual)$15.28

CapEx CAGR (5Y)0.04%

Tangible BV CAGR (5Y)-10.93%

26-Week Price Return-23.33%

Quick Ratio (Annual)0.67x

13-Week Price Return-3.22%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)0.85x

Enterprise Value$12.32B

Revenue / Share Growth (5Y)28.39%

Asset Turnover (TTM)1.44x

Book Value / Share Growth (5Y)-6.50%

Revenue / Employee (Annual)$401,600

Pretax Margin (Annual)21.44%

Cash / Share (Annual)$17.56

3-Month Return Std Dev55.31%

Gross Margin (5Y Avg)29.47%

Net Income / Employee (TTM)$73,100

EBITDA CAGR (5Y)24.73%

EBITDA Interim CAGR (5Y)23.01%

ROE (Last FY)98.27%

Net Interest Coverage (Annual)100.53x

EPS Basic Excl Extra (Annual)$15.28

P/FCF (TTM)18.25x

Receivables Turnover (TTM)7.73x

EV / Free Cash Flow (TTM)17.33x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$15.89

Receivables Turnover (Annual)7.24x

ROI (TTM)120.89%

P/S Ratio (TTM)4.84x

Pretax Margin (5Y Avg)19.77%

Revenue / Share (Annual)$85.69

Tangible BV / Share (Annual)$15.04

Forward P/E25.48x

Free OCF CAGR (5Y)24.56%

Price vs S&P 500 (52W)30.36%

P/E Ratio (TTM)28.18x

EPS Growth TTM (YoY)21.30%

Year-to-Date Return-19.12%

5-Day Price Return0.62%

EPS Normalized (Annual)$15.28

ROA (5Y Avg)17.65%

Net Profit Margin (Annual)17.83%

Month-to-Date Return1.60%

Cash Flow / Share (TTM)$9.33

EBITD / Share (Annual)$19.07

EPS Growth (3Y)28.02%

Operating Margin (Annual)21.14%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)17.55x

ROI (5Y Avg)54.63%

P/E Excl Extra (TTM)28.18x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$15.89

P/TBV (Quarterly)24.27x

P/B Ratio (Annual)34.46x

Pretax Margin (TTM)21.35%

Book Value / Share (Annual)$16.22

Price vs S&P 500 (13W)-11.48%

Net Margin Growth (5Y)2.58%

Beta1.18x

P/FCF (Annual)19.03x

Revenue / Share (TTM)$92.48

ROE (TTM)120.89%

52-Week Low$293.20

vGradeD

gGradeA

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q1 264.28est. 3.96

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

2.61

3.53

3.60

Industry Peers — R&D — Physical Sciences(15)

Symbol	Value Score	Growth Score	Momentum Score	Price
MEDPMedpace Holdings, Inc. Common Stock	D	A	B	$454.25
IQVIQVIA Holdings Inc.	C	B	C	$183.45
INCYIncyte Genomics Inc	C	A	B	$102.38
ICLRIcon Plc	C	C	B	$149.45
CRLCharles River Laboratories International, Inc.	D	D	B	$181.34
ABSIAbsci Corporation Common Stock	F	F	A	$6.40
NRCNRC Health Common Stock	D	D	B	$19.14
OABIOmniAb, Inc. Common Stock	D	C	A	$2.48
MXCTMaxCyte, Inc. Common Stock	C	D	C	$1.14
ONMDOneMedNet Corp Class A Common Stock	D	C	B	$0.68
BIAFbioAffinity Technologies, Inc. Common Stock	C	F	B	$1.73

About

Medpace is a late-stage contract research organization providing comprehensive drug development and clinical trial services to small and midsize biotech, pharmaceutical, and medical device companies. The company offers additional capabilities including bioanalytical laboratory services and imaging solutions. With over 5,400 employees across 40 countries and 30+ years of industry experience, Medpace maintains global operations headquartered in Cincinnati, Ohio, with a substantial presence across North America, Europe, Asia, and other regions.